REGISTER ON CMA WEBSITE
Join our Virtual Grand Rounds: Opioid Treatments: Practical Guidance for Clinicians on Tuesday, October 10, 2023, from 12:00 p.m PT to 1:00 p.m. PT
With California's escalating opioid epidemic, all clinicians should be well-versed in treating patients with opioid use disorder. Now, with naloxone available over the counter, everyone can be empowered to reverse opioid overdoses. But how many of us are comfortable prescribing buprenorphine, referring to methadone treatment, or using naloxone? Marlene Martin, M.D., an associate professor of medicine at UCSF, director of the UCSF Addiction Care Team and hospitalist based in San Francisco General Hospital, will educate us in using these important and lifesaving medications. Additionally, James Watt, M.D., MPH, will present updates on COVID-19 and the current status of vaccine recommendations for the fall.
Virtual Grand Rounds: Opioid Treatments: Practical Guidance for Clinicians may be applied to meet the one-time eight-hour MATE Act training requirement.
Featured Speaker:
 |
|
Epidemiology Update for California - James Watt, M.D., MPH, Assistant Deputy Director, California Department of Public Health, Center of Infectious Diseases |
 |
|
Opioid Treatment - Marlene Martin, M.D., Director, UCSF Addiction Care Team, and Hospitalist, San Francisco General Hospital |
This event will be moderated by Kimberly Newell Green, M.D.
 |
|
Kimberly Newell Green, M.D., CMA Trustee; Associate Clinical Professor, University of California, San Francisco |
As a result of this activity, participants should be able to:
- Discuss the current epidemiology of COVID-19 in California
- Summarize the current fall COVID-19 and influenza vaccine recommendations
- Incorporate the use of Buprenorphine in treating opioid use disorder
- Refer patients to methadone treatment
- Use naloxone to reverse opioid overdose
Disclosure:
The following speakers disclose no relevant financial relationships with ineligible companies: Kimberly Newell Green, M.D.; Marlene Martin, M.D.
James Watt, M.D., MPH, has disclosed a stockholder relationship with the following ineligible entities: Abbvie, Bristol Myers Squibb, Eastman Chemical, Procter and Gamble, and Becton Dickinson.
These relationships have been mitigated through presentation review.
All other planners, staff and others involved with this activity have reported no relevant financial relationships with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
This activity has not received commercial support.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the California Medical Association (CMA) and California Health and Human Services Agency. CMA is accredited by ACCME to provide continuing medical education for physicians.
The California Medical Association designates this live activity for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
